Chemical Biology and Drug Design

MAY 10, 2025

ABSTRACT Carprofen, a nonsteroidal anti-inflammatory drug (NSAID) derived from propanoic acid, is known for its analgesic and antipyretic properties. With ongoing research pushing the boundaries of its potential, carprofen remains a promising candidate for innovation in drug development and treatment strategies.

Small Molecule

Drug Patent Watch

FEBRUARY 12, 2025

Accelerating Generic Drug Development: Strategies for Success As a pharmaceutical professional, you know how crucial it is to navigate the complex landscape of generic drug development. The generic drug development process involves several stages, from patent research to regulatory approvals.

Drug Development

Drug Target Review

DECEMBER 6, 2024

In drug discovery and biological research, the scientists workflow often follows a structured and iterative approach to ensure accuracy, reproducibility and scientific integrity. As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics.

RNA

Drug Target Review

APRIL 7, 2025

In a recent survey conducted by ICON, Plc, biomarker selection was identified by 35 percent of respondents as a top challenge among drug developers for phase I trials, second only to navigating regulatory compliance (- 38 percent). Silver Spring (MD): Food and Drug Administration (US); 2016-. 113:9861002.

Clinical Development

Drug Target Review

JANUARY 14, 2025

In the next article, we will discuss the tools scientists can use to execute the workflow described in Figure 1. Figure 1: High-level workflow for early drug discovery. As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics.

Drugs

Drug Target Review

JUNE 9, 2025

A personal journey to Alltrna Michelle Werner’s career has spanned over 20 years in the pharmaceutical industry, where she developed her expertise in oncology drug development at leading companies such as Bristol Myers Squibb, AstraZeneca, and Novartis.

Disease

Drug Target Review

JUNE 11, 2025

Drug development is plagued by complex challenges, but multimodal AI is unlocking new opportunities. By integrating diverse data sources – from genomics to clinical insights – this approach is accelerating drug discovery, improving patient stratification and boosting success rates. Highlighting data integration.

Drugs

Drug Target Review

APRIL 30, 2025

Faster time-to-market and reduced costs. By integrating AI into the manufacturing process, the developer achieved higher consistency across batches, improved overall product quality, and reduced time-to-market – all critical factors in ensuring patients receive timely and effective treatment. The result?

Drugs

The Premier Consulting Blog

APRIL 13, 2025

On April 10, 2025, the US FDA announced that it has a long-term plan to eliminate conventional animal testing in drug development, starting with monoclonal antibodies (mAbs).[ from approved products in other countries) to inform doses and development. Legislation with delayed implementation In 2021, the FDA Modernization Act 2.0

Animal Testing

Alta Sciences

MARCH 4, 2025

Over time, this group of professionals evolved and grew, having regular stakeholder interactions with the FDA and Controlled Substances staff to discuss requirements for drug developers. I have spent the better part of my career working to make drugs safer. About the Author Beatrice Setnik, PhD, Chief Scientific Officer.

Clinical Trials

Perficient: Drug Development

MAY 27, 2025

Using the Blog plugin, individuals can publish articles, share insights, and engage with readers. Shopaholic another powerful plugin with extensible architecture and marketing features. Ideal for developers building tailored eCommerce sites with full control over layout and functionality.

Engineering

Alta Sciences

NOVEMBER 15, 2024

4 Essential Topics to Cover in Your First CRO Meeting pmjackson Fri, 11/15/2024 - 19:22 Starting a partnership with a contract research organization (CRO) is a sometimes intimidating—yet exciting—first step in your drug development journey. It’s equally important to communicate your long-term plans.

Drug Development

PPD

JULY 18, 2025

This blog reviews six of the most valuable aspects of regulatory communication and relationship building that, when executed properly, are often able to enhance a therapy’s chance of getting to market. When a company applies these approaches, even small or novice drug developers will see increased efficiency.

Regulations

Drug Target Review

APRIL 7, 2025

GPCRs are critical targets for drug development due to their involvement in numerous disease pathologies, with many medications working by either activating or inhibiting these receptors. 2022) Why 90% of clinical drug development fails and how to improve it?, References Sun D, et al. doi:10.1016/j.apsb.2022.02.002.

Fragment Screening

Drug Target Review

DECEMBER 9, 2024

Baker’s model could revolutionise drug development, synthetic biology, and nanotechnology, opening possibilities for new medical treatments, vaccines, nanomaterials, and sensors. This boosts the inventors reputation, making it easier to secure funding for development and commercialisation.

Engineering

Drug Target Review

JULY 7, 2025

Non-human primates (NHPs), such as macaques and cynomolgus monkeys, have long served as a cornerstone in preclinical drug development due to their close genetic, anatomical and physiological resemblance to humans. Food and Drug Administration (FDA). Bailey J, et al. Trends in Non-Human Primate Use for Research and Testing.

Drug Research

Drug Target Review

APRIL 14, 2025

The antibiotic market has long faced significant barriers to innovation, with structural issues that make it difficult for new antibiotics to gain traction. As the demand for novel antibiotics remains limited due to the preference for cheaper generics, the market has struggled to incentivise much-needed breakthroughs.

Therapies

Drug Target Review

AUGUST 8, 2025

Market outlook: A new wave of biologics The biologics market is evolving rapidly. While monoclonal antibodies and antibody-drug conjugates continue to drive therapeutic pipelines, bispecific T-cell engagers (TCEs) are gaining momentum as a versatile and scalable class of immunotherapies. References PatSnap Synapse.

Engineering

BioPharma Drive: Drug Pricing

JULY 14, 2025

Stock via Getty Images A new kind of sleeplessness medicine developed by Takeda met its goals in late-stage testing, positioning the company to capitalize on what Wall Street analysts believe could be a multibillion-dollar market opportunity. You can unsubscribe at anytime. Track funding rounds here. inhibitors. inhibitors.

Drugs

Perficient: Drug Development

FEBRUARY 13, 2025

Best for: Blog posts, marketing pages, documentation. Best for: Product pages, news articles, dynamic content with occasional updates. Uses getStaticProps() to prefetch data only once at build time. Incremental Static Regeneration (ISR) Rebuilds static pages in the background at set intervals (without a full redeploy).

Engineering

Drug Patent Watch

JANUARY 30, 2025

Maximizing Patent Protection: Strategies for Pharmaceutical Marketers As a pharmaceutical marketer, you know how crucial it is to protect your patented drug's market share. This exclusivity is a result of the patent protection granted to the drug's developer. Read the full article here: [link]

Marketing

Drug Patent Watch

FEBRUARY 26, 2025

In this article, we'll delve into the world of drafting drug patent applications for biologic drugs. To draft a strong patent application, you need to understand the nuances of biologic drug development, including the production process, stability, and formulation. Read the full article here: [link]

Drugs

Perficient: Drug Development

MARCH 18, 2025

Customer KM Agent Keeps knowledge articles up to date. Sales and Marketing Sales Qualification Agent Focuses on high-priority sales opportunities. IT Helpdesk Resolves issues and creates/view support tickets. Case Management Offers automated support and creates cases. Self-Help Helps customer service agents resolve issues faster.

Production

Drug Target Review

JUNE 18, 2025

In early-stage drug discovery, pressure is nothing new. However, when that pressure is compounded by political shifts, market volatility and rising expectations from the global pharmaceutical industry, the old ways of working start to crack. We helped them go from reduced early-stage drug development by half” he says.

Drugs

Perficient: Drug Development

DECEMBER 8, 2024

In the ever-evolving landscape of digital marketing, data is the key to success. Salesforce Marketing Cloud (SFMC) provides a wide array of tools to help marketers harness the power of data, and at the forefront is Analytics Builder. Regularly Review and Refine Marketing is an iterative process. What is Analytics Builder?

Marketing

Drug Target Review

JUNE 5, 2025

Dr Aaron Haubner, Senior Manager of North America Medical Affairs and Market Access at Terumo Blood and Cell Technologies , reveals that while promising new treatments emerge, urgent partnerships are needed to ensure this essential blood therapy reaches the patients who need it most. 2023 Aug;40(8):3543-3558. doi: 10.1007/s12325-023-02545-7.

Disease

Perficient: Drug Development

NOVEMBER 14, 2024

On the flip side, if you have a very technically robust team, you don’t want to handcuff them and leave them frustrated with limitations that could impact marketing opportunities that could lead to higher ROI. Additional considerations that can help guide your choice in toolset would be future goals and initiatives. Is a rebrand coming soon?

International

Drug Patent Watch

DECEMBER 17, 2024

Contract Development and Manufacturing Organizations (CDMOs) are at the forefront of this shift, playing a crucial role in bringing innovative therapies to market. Today, they’re strategic partners in drug development and manufacturing, offering end-to-end solutions that can make or break a pharmaceutical company’s success.

Pharmaceuticals

Drug Target Review

JULY 29, 2025

Kyle notes that “clinical trials face costly delays, inefficient resource allocation, and even standstill or stalling of trials, ultimately resulting in the failure to bring crucial treatments to market.” With limited resources and growing demands, it becomes even more critical to find a way to streamline financial operations.

Clinical Trials

BioPharma Drive: Drug Pricing

JUNE 11, 2025

In a research note on Wednesday, RBC Capital Markets analyst Leonid Timashev estimated peak yearly sales of the drug could reach nearly $640 million. billion buyout of Blueprint Medicines is the sector’s second-largest M&A deal this year and represents the highest value paid for an immune drug developer since April 2023.

FDA

LifeSciVC

APRIL 17, 2025

I realize this moment in time is especially jarring to be discussing failure, when so many of our core institutions for novel thesis generation (NIH), drug development and approval (FDA), and the basic tenets of our biotech economy are in flux. Many thanks also to Akshay Vaishnaw for providing feedback on this post.

International

BioPharma Drive: Drug Pricing

JULY 28, 2025

You can unsubscribe at anytime.

Clinical Trials

Drug Target Review

MAY 26, 2025

With a particular focus on biologics, cell, and gene therapies, Galbraiths work is centred on equipping drug developers with the tools, insights, and support needed to advance their therapies from concept to clinic. Harnessing emerging technologies The rapid pace of technological innovation is reshaping the landscape of drug discovery.

Drug Development

BioPharma Drive: Drug Pricing

JUNE 26, 2025

CBER’s new chief has argued for more stringent measures of assessing drugs for cancer and rare diseases, suggesting he might push for higher standards in the review of medicines under his division's purview. You can unsubscribe at anytime.

Disease

BioPharma Drive: Drug Pricing

JULY 10, 2025

Deep Dive Library Events Press Releases Topics Sign up Search Sign up Search Pharma Biotech FDA Clinical Trials Deals Drug Pricing Gene Therapy An article from Dive Brief Moderna COVID vaccine gets full approval for children The approval comes amid regulatory upheaval under HHS head Robert F. You can unsubscribe at anytime. Kennedy Jr.,

Vaccine

BioPharma Drive: Drug Pricing

JULY 10, 2025

Published July 10, 2025 Ben Fidler Senior Editor post share post print email license Soleno Therapeutics on July 10, 2025 announced preliminary sales for its new Prader-Willi Syndrome drug Vykat. Until Vykat came along, though, no drug therapies were specifically approved to curb the all-consuming hunger that hallmarks the condition.

Drugs

Drug Target Review

MAY 5, 2025

While another pandemic has not reached our doorstep at least not yet our sense of urgency and creativity should be the fuel for reimagining clinical development processes. The staggering average cost of bringing a drug to market (more than $1 billion) is accompanied by a dismal success rate of justfive to seven percent.

Clinical Development